Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: December 2013

TherapeuticsMD (TXMD) Announces Receipt of Patent Allowance Covering Platform Technology of Oral Combination of Bioidentical 17-Estradiol and Progesterone

Posted on December 10, 2013 by MissionIR

Women’s healthcare company TherapeuticsMD announced it has received a notice of allowance from the U.S. Patent and Trademark Office regarding its U.S. patent application 13/684,002, “Natural Combination Hormone Replacement Formulations and Therapies.” The patent application covers TherapeuticsMD’s technology TX 12-001-HR, … Continue reading →

Posted in Small Cap News | Leave a comment

Methes Energies (MEIL) Poised for Rapid Expansion to Secure Leading Global Position, Says Wall Street Cheat Sheet

Posted on December 9, 2013 by MissionIR

Renewable energy small-cap Methes Energies Monday was featured in an article by portfolio manager James Ratz, also a contributor to Wall Street Cheat Sheet. The article surmises Methes’ potential as a global leader in the renewable energy industry based on … Continue reading →

Posted in Methes Energies International MEIL | Leave a comment

RFMD, Inc. (RFMD) Enhances Power Efficiency of New Marquee Android Smartphone with Cutting-Edge Envelope Tracking Power Amplifiers and Antenna Control Solutions

Posted on December 9, 2013 by MissionIR

RFMD, a leader in the design and manufacture of high-performance radio frequency solutions worldwide, announced today that its envelope tracking (ET) power amplifiers, antenna switch module, diversity switches, and antenna tuner are built into the latest flagship Android smartphone, made … Continue reading →

Posted in Small Cap News | Leave a comment

Boston Therapeutics, Inc. (BTHE) Takes Firm Stance Against Type 2 Diabetes, Backed by High-Potential Candidate Pipeline

Posted on December 9, 2013 by MissionIR

Boston Therapeutics is developing a pipeline of therapeutic molecules based on complex carbohydrate chemistry. This pipeline currently carries three compounds that are being fine-tuned and tested in hopes that each will become a commercialized therapeutic treatment for diabetes. Drug candidate … Continue reading →

Posted in Boston Therapeutics Inc. BTHE | Leave a comment

Nutranomics, Inc. (NNRX) Recruits MD and PhD Microbiologist as Supply Chain Manager

Posted on December 9, 2013 by MissionIR

Nutranomics announced that it has appointed Enkhmart (Michelle) Dudleenamjil, MD, Ph.D., to the position of Supply Chain Manager. “Michelle brings a wealth of knowledge and nutraceutical industry experience to Nutranomics, including a Ph.D. from Brigham Young University in microbiology and … Continue reading →

Posted in Small Cap News | Leave a comment

Methes Energies International Ltd. (MEIL) Signs LOI to Acquire OTC Energy Technologies, Inc.

Posted on December 9, 2013 by MissionIR

Methes Energies, a renewable energy company with a variety of products and services available to biodiesel fuel producers, has signed a letter of intent (LOI) to acquire the assets of OTC Energy Technologies (OTC), including all of OTC’s technologies, potential … Continue reading →

Posted in Methes Energies International MEIL | Leave a comment

Car Charging Group, Inc. (CCGI) Raises $10M, Allocated to Balance Sheet and Expansion Plans

Posted on December 9, 2013 by MissionIR

CarCharging, a nationwide provider of electric vehicle (EV) charging services, reports that it has raised $10 million with institutional investors, which the company intends to use to strengthen its balance sheet and to provide additional operating capital for expansion. “We … Continue reading →

Posted in Small Cap News | Leave a comment

China BAK Battery, Inc. (CBAK) Video Chart for Friday, December 6, 2013

Posted on December 6, 2013 by MissionIR

CBAK is holding a solid support at $1.95 as part of an uptrend that began in May. A move upward on Thursday has the chart positioned to try and make the next leg up in a series of higher highs … Continue reading →

Posted in Small Cap News, Technical Analysis | Leave a comment

TG Therapeutics (TGTX) Initiates Combination Clinical Trial of TG-1101 with Ibrutinib for CLL and MCL Patients

Posted on December 6, 2013 by MissionIR

Clinical-stage biopharmaceutical company TG Therapeutics announced it has commenced a multicenter Phase 2 clinical trial to evaluate the safety and efficacy of the combination of TG-1101 (ublituximab) and ibrutinib (IMBRUVICA) for patients with chronic lymphocytic leukemia (CLL) and mantle cell … Continue reading →

Posted in Small Cap News | Leave a comment

Bridgeline Digital, Inc. (BLIN) Releases iAPPS Social, Fifth Module to its iAPPS Platform

Posted on December 6, 2013 by MissionIR

Bridgeline Digital, The Digital Engagement Company™, specializing in enabling its customers to maximize the performance of their mission critical websites, intranets, and online stores, announced today that it has released the fifth module to its iAPPS platform, iAPPS Social. This … Continue reading →

Posted in Small Cap News | Leave a comment